Purdue launches RxSafetyMatters.org
STAMFORD, Conn. — Purdue Pharma has launched a new website designed to combat abuse of prescription drugs, the company said Wednesday.
The website, RxSafetyMatters.org, is designed to help healthcare professionals, police and community organizations combat prescription drug diversion and abuse. Purdue is the developer of OxyContin (oxycodone), an extended-release painkiller that is frequently a target of drug abusers.
“Purdue is committed to working with healthcare professionals, law enforcement and local communities to help curb illegal diversion and abuse of medications while also ensuring that these medicines remain available for appropriate medical use,” Purdue president and CEO John Stewart said. “The best chance for making a significant impact on the abuse of prescription drugs is greater collaboration among the many sectors of our society that recognize the serious public health problem that this abuse represents.”
Its time that Purdue put its money into supporting Recovery Programs and paying for the funerals of those who have died due to addiction of opioids that can be traced back to OXY. Working with the healthcare Professionals to whom they pandered the drugs in the first place makes little to NO sense. I do agree that OXYCONTIN has a place, it belongs IN the hospitals, and in Hospice Care. It should ALMOST never be given as a take home script. This MIS-REPRESENTATION of the drug has caused serious addiction problems across the US and has lead to many Deaths... The statement made by John Stewart is too little to late. And it truly shows his lack of commitment to the real problem his company has caused. If he thinks if can be covered up with this collaboration he is sadly mistaken. Re-Marketing the drug for Severe pain only, and pulling it back out of take-home scripts regiment that has brought them BILLIONS of dollars is the ONLY way to stop the endless Tsunami he has created.
FDA committee doesn’t recommend regulatory approval for dapagliflozin
WILMINGTON, Del. — A Food and Drug Administration committee of experts has advised against approving a drug for Type 2 diabetes made by AstraZeneca and Bristol-Myers Squibb, the companies said Tuesday.
The FDA’s Endocrinologic and Metabolic Drugs Advisory Committee voted 9-6 against recommending approval for dapagliflozin, saying that data from a two-year clinical trial program that included about 6,000 people did not support the drug’s approval for use in patients along with changes to diet and exercise.
The FDA is not required to follow advisory committee votes but usually does. Shares of AstraZeneca were down about 0.6%, while Bristol’s shares were up about 0.17% Wednesday morning.
No comments found
Cardinal Health’s Retail Business Conference highlights new services
LAS VEGAS — Cardinal Health on Wednesday morning announced that the wholesaler’s annual national trade show for independent pharmacies marks the largest in the event’s more than 20-year history, with nearly 7,000 attendees.
This year’s Retail Business Conference features a 100,000-sq.-ft. trade show floor, highlighting buying opportunities with more than 330 exhibitors. At the event, pharmacists can access more than 50 continuing education courses and also can access seven full- or half-day continuing pharmacy education courses on issues ranging from pharmacy-based immunization delivery to helping patients manage cardiovascular risk.
“We believe this is one of the largest gatherings of retail independent pharmacies in one place, ever,” Cardinal Health SVP retail independent sales Steve Lawrence said. “[Retail Business Conference] is an outstanding opportunity for independent pharmacy owners to network with peers from across the country, tap into more continuing education courses than they’ll find anywhere else and learn about the many ways Cardinal Health can help them improve the efficiency and profitability of their businesses.”
New services highlighted at this year’s RBC include:
Enhancements to Cardinal Health’s Front-End Product Management solution, which helps pharmacies maximize sales of nonprescription items. Pharmacy owners now can benchmark and compare their own front-of-store point-of-sale data with that of other similar-size stores with comparable demographics, giving them valuable access to the front-end management best practices of their peers;
New pharmacy business assessments of all aspects of a pharmacy’s operations, conducted by an experienced pharmacy business consultant. Following the assessment, participating pharmacies receive store-specific, actionable recommendations on everything from store aesthetics — how a store can improve its overall look and feel — to how to improve back-end accounts receivable and inventory management processes;
A new suite of human resources services that help pharmacy owners navigate all aspects of employee management. The new services provide quick-and-easy online access to hiring guides and performance management tools, specifically created to meet the needs of small business owners. Pharmacy owners also can get one-on-one, personal phone consultations about how to most appropriately address specific employee issues;
An exclusive new “gift card” program that helps independent pharmacies offer customers the convenience of purchasing gift cards for national retailers and restaurants (ranging from Macy’s to Applebee’s), while visiting their community drug store; and
Enhancements to Order Express, the new online ordering system that the company introduced at last year’s RBC. Order Express now integrates with the company’s inventory management and mobile ordering tools, providing community pharmacists an even more convenient, seamless online ordering experience.
In addition, Cardinal Health has created a program for the children of attendees at the conference, as many community pharmacists bring their families to the show. Called “Camp Cardinal Health,” the program provides children of all ages with four days of age-appropriate, on- and off-site entertainment opportunities and special events.
No comments found